Evidence, Economics, and Politics: Australia’s Experiment in Evidence-Based Medicine
PRI Event
Start :
Friday, December 15, 2006 07:30 AM
End :
Friday, December 15, 2006 10:30 AM
Evidence, Economics, and Politics: Australia’s Experiment in Evidence-Based Medicine
Friday, December 15, 2006 7:30 a.m. - 10:30 a.m St. Regis Hotel 125 3rd Street (near Mission) San Francisco, CA 94103
Registration and Continental Breakfast: 7:30 a.m. Panel Discussion: 8:00 a.m.
Australia’s National Health Systems (NHS) provides universal, tax-financed coverage to all citizens. To control the cost of medicines, NHS created a Pharmaceutical Benefits Advisory Committee (PBAC) to advise whether and, if so, how government should subsidize drugs. A central feature of PBAC is cost-effectiveness research. With U.S. policymakers searching for ways to rein in Medicare and Medicaid drug spending, the Australian experience assumes special relevance.
Join CHI - California Healthcare Institute, Pacific Research Institute, and policy experts from Australia and the U.S. for a discussion of the promise and pitfalls of cost-effectiveness analysis, a subject already of intense interest to the U.S. Food and Drug Administration (FDA) and Centers for Medicare and Medicaid Services (CMS).
Moderator:
- John R. Graham
Director, Health Care Studies, Pacific Research Institute, and former Director of Health & Pharmaceutical Policy Research at Canada’s Fraser Institute
Panelists:
- Kwabena O.M. Adubofour, MD
Medical Director, Fifth Street Medical Center - South Stockton, CA View Powerpoint Presentation
- Meryl Comer
Journalist and Caregiver
- Randolph Frankel
Vice President, Public Affairs & Government Relations, IMS Health
- Marjorie Ginsburg
Executive Director, Sacramento Healthcare Decisions View PowerPoint Presentation
- Ruth Lopert
Harkness Fellow in Health Care Policy, George Washington University and Principal Advisor, Pharmaceutical Policy Taskforce, Commonwealth Department of Health and Ageing, Canberra, Australia View Powerpoint Presentation
- Peter J. Pitts
Co-Founder and President, Center for Medicines in the Public Interest, and former FDA Associate Commissioner for External Relations
There is no cost to attend this conference, however space is limited. Register online by Wednesday, December 13, 2006
 | PRI's John R. Graham moderating panel discussion
|  | PRI Board Member, Mike Carpenter and guest
|  | Mike Carpenter, John R. Graham, Meryl Comer, and Governor Pete Wilson
|
Questions? Contact Shawn Bonsack (bonsack@chi.org or 858-551-6677). Cindy Chin (cchin@pacificresearch.org or 415-955-6110).
Sponsors: California Healthcare Institute Pacific Research Institute
|